Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-03-16-Speech-4-027"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2006-03-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Community action programme in the field of health (2007-2013) (debate)2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20060316.5.4-027"2
lpv:hasSubsequent	lp_eu:2006-03-16-Speech-4-0282
lpv:speaker	lp:Johannes Blokland2
lpv:spokenAs	substitute; TRAN (2004-09-15--2007-01-14)3 member; LIBE (2004-09-14--2007-01-14)3 substitute; Delegation for relations with the People's Republic of China (2004-11-18--2006-12-12)3 vice-chair; ENVI (2004-07-22--2007-01-14)3 treasurer; IND/DEM (2004-07-26--2007-02-12)3 member; Delegation to the EU-Armenia, EU-Azerbaijan and EU-Georgia Parliamentary Cooperation Committees (2004-09-15--2009-07-13)3 member; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2004-09-15--2009-07-13)3 unknown; ChristenUnie - Staatkundig Gereformeerde Parti (2004-07-20--2009-07-13)3
lpv:translated text	". Mr President, first of all, I should like to thank Mr Trakatellis for his work on this dossier. His commitment to improving public health in Europe is commendable. Whilst I can support the gist of the report, I should nevertheless like to make three observations. Firstly, with regard to the budget, Amendment 64 increases it substantially, albeit only indicatively. In my view, this amendment does not belong in this report, since the level of the budget is not decided upon today, but depends on the outcome of the negotiations on financial perspectives. Secondly, I should like to speak out in favour of Amendment 148 of the Group of the European People’s Party (Christian Democrats) and European Democrats. Genetic screening can be a valuable addition to the present diagnostic techniques, but only if it is used in an ethically responsible manner. We must, for example, prevent insurance companies from excluding certain people from their policies on the basis of genetic profiling. Lastly, I should like to draw the Commissioner’s attention to the very bureaucratic manner in which the research budget is now shared out. It has come to my notice that a single application can cost as much as a few thousand euros. Also, applicants are left in the dark as to the criteria on which basis they will eventually be tested and as to the basis on which applications can be granted or turned down. Moreover, whilst the Commission is very strict on the applicants when they exceed deadlines, there are no repercussions when the Commission postpones a decision. Needless to say, this leads to much frustration. I suggest we introduce a preliminary procedure in which applications are tested on a limited number of points. Full applications would then be requested only of the projects that have real chances of success. This will reduce the work pressure in the Commission and can also considerably reduce the burden on the part of the applicants. I should like to hear a reaction from the Commissioner on this."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph